3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting clinical focus due to initial information suggesting unique pharmacological characteristics. Present analyses suggest that https://www.pinterest.com/pin/1140888518124046392/